¸»±â¾ÏȯÀÚ¿¡¼ Ç÷Àå ³»µ¶¼Ò ³óµµ°¡ »ýÁ¸±â°£¿¡ ¹ÌÄ¡´Â ¿µÇâ
The Effects of Plasma Endotoxin Level on Survival Time of Terminally Ill Cancer
Journal of Hospice and Palliative Care 2014³â 17±Ç 2È£ p.57 ~ p.65
ÀÌÁø¾Æ(Lee Jin-Ah) - °í·Á´ëÇб³ Àǰú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
À±È£¹Î(Yoon Ho-Min) - °í·Á´ëÇб³ Àǰú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
ÃÖÀ±¼±(Choi Youn-Seon) - °í·Á´ëÇб³ Àǰú´ëÇÐ °¡Á¤ÀÇÇб³½Ç
¿¬Á¾Àº(Yeon Jong-Eun) - °í·Á´ëÇб³ Àǰú´ëÇÐ ³»°úÇб³½Ç
ÀÌÁØ¿µ(Lee June-Young) - °í·Á´ëÇб³ Àǰú´ëÇÐ Åë°èÇб³½Ç
Abstract
¸ñÀû: ¸»±â¾ÏȯÀÚÀÇ ¿©¸í ¿¹ÃøÀº Ä¡·áÀÇ À̵æ°ú À§Çظ¦ ÆÇ´ÜÇÏ´Â Àã´ë°¡ µÇ°í, ÀûÀýÇÑ ÀÇ·á ÁßÀç Á¦°ø ¹× ȯÀÚÀÇ ÀÚÀ²¼º¿¡ ±âÃÊÇÑ ÀÇ»ç°áÁ¤¿¡ Áß¿äÇÑ ±âÁØÀÌ µÈ´Ù. ƯÈ÷ ¸¹Àº ¼öÀÇ ¸»±â¾ÏȯÀÚ´Â ´Ù¹ß¼º Àå±â ºÎÀüÀ¸·Î »ç¸Á¿¡ À̸£±â ¶§¹®¿¡ º» ¿¬±¸¿¡¼´Â À̸¦ ¹Ý¿µÇÒ ¼ö ÀÖ´Â Ç÷Àå ³»µ¶¼Ò ³óµµ¿Í »ýÁ¸±â°£°úÀÇ ¿¬°ü¼ºÀ» ¾Ë¾Æº¸°íÀÚ ÇÏ¿´´Ù.
¹æ¹ý: 2009³â 4¿ùºÎÅÍ 10¿ù±îÁö 6°³¿ù µ¿¾È, ¸¸ 20¼¼ ÀÌ»óÀÇ ¸»±â¾ÏȯÀÚ 56¸íÀ» ´ë»óÀ¸·Î Ç÷Àå ³»µ¶¼Ò ³óµµ¸¦ ÃøÁ¤Çϰí, »ýÁ¸±â°£À» Á¶»çÇÏ¿´´Ù. ³ªÀÌ, ¼ºº°, ¿ø¹ß ¾Ï ºÎÀ§, ¾Ï Ä¡·á °æ·Â, ÀüÀÌ¿©ºÎ, Åõ¾à»óȲ ¹× Ȱ·Â ÁõÈÄ, Karnofsky ¼öÇàÁö¼ö µîÀÇ ½Åü°Ë»ç, ¹éÇ÷±¸ ¼ö, Ç÷»ö¼Ò, ÀûÇ÷±¸¿ëÀû·ü, aspartate aminotransferase, alanine aminotransferase C-¹ÝÀÀ¼º ´Ü¹éÁú, ÃÑ ºô¸®·çºó, ³»µ¶¼Ò µîÀÇ Ç÷¾×°Ë»ç¸¦ ½ÃÇàÇÏ¿´´Ù.
°á°ú: Ç÷Àå ³»µ¶¼Ò ³óµµ, ¼ºº°, ³ªÀÌ, ¹éÇ÷±¸ ¼ö, Ç÷»ö¼Ò, ÀûÇ÷±¸ ¿ëÀû·ü, AST, ALT, ÃÑ ºô¸®·çºó, C-¹ÝÀÀ¼º ´Ü¹éÁú, ÅëÁõ°µµ¸¦ ´Üº¯·® ºÐ¼®ÇÑ °á°ú Ç÷Àå ³»µ¶¼Ò ³óµµ´Â »ýÁ¸±â°£°ú Åë°èÀûÀ¸·Î À¯ÀÇÇÑ °ü°è¸¦ º¸ÀÌÁö´Â ¾Ê¾ÒÀ¸³ª, ´Üº¯·® ºÐ¼®¿¡¼ »ýÁ¸±â°£¿¡ À¯ÀÇÇÑ ¿µÇâÀ» ¹ÌÄ¡´Â ¼ºº°, ¹éÇ÷±¸ ¼ö, ÃÑ ºô¸®·çºóÀ» Æ÷ÇÔÇÏ¿© ½ÃÇàÇÑ ´Ùº¯·® ºÐ¼®¿¡¼ Ç÷Àå ³»µ¶¼Ò ³óµµ´Â »ýÁ¸±â°£°ú Åë°èÀûÀ¸·Î À¯ÀÇÇÑ °ü°è°¡ ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ´Ù.
°á·Ð: ´Ù¹ß¼º Àå±â ºÎÀü°ú °ü·ÃÀÌ ÀÖ´Â Ç÷Àå ³»µ¶¼Ò ³óµµ´Â »ýÁ¸±â°£ ¿¹ÃøÀÎÀڷμ ¾²ÀÏ ¼ö ÀÖ´Â °¡´É¼ºÀ» º¸¿© ÁÖ¾ú´Ù.
Purpose: Since most terminally ill cancer patients die of multiple organ failure, plasma endotoxin concentration levels may be used to predict the life expectancy. This study was performed to evaluate the clinical significance of endotoxin level in plasma as a prognostic factor for survival in patients with terminal cancer.
Methods: This study was conducted with 56 terminally ill cancer patients, above 20 years old, from April 2009 through October 2009. Demographic characteristics, Karnofsky performance status, and survival time were evaluated. We analyzed blood levels of white blood cell hemoglobin, hematocrit, aspartate aminotransferase, alanine aminotransferase, c-reactive protein, total bilirubin and endotoxin in each patient.
Results: We considered following variable for univariate analysis: plasma endotoxin level, sex, age, WBC, hemoglobin, hematocrit, AST, ALT, total bilirubin, CRP and severity of pain. Univariate analysis did not show a significant association between plasma endotoxin level and survival time. However, in a multivariate analysis with factors that were found to be significantly associated with survival sex, WBC count and total bilirubin level in univariate analysis, high levels of plasma endotoxin and short survival time were significantly related.
Conclusion: Plasma endotoxin level could be used as a prognostic factor to predict the life expectancy of terminally ill cancer patients.
Ű¿öµå
³»µ¶¼Ò, ¸»±â µ¹º½, ¾Ï, ¿©¸í ¿¹Ãø, È£½ºÇǽº
Endotoxins, Terminal care, Neoplasm, Prognosis, Hospice care
KMID :
0856920140170020057
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)